header-logo header-logo

*Partner copy* Bridging the gap – when a hair drug test is not enough

04 April 2025 / Marie Law
Issue: 8111 / Categories: Features , Family , Health
printer mail-detail
214779
Marie Law, Head of Toxicology at AlphaBiolabs, discusses the many benefits of oral fluid drug testing for child welfare and protection matters

Drug testing plays a crucial role in safeguarding children and informing court decisions. Whether used in private law cases—such as custody disputes—or during child protection proceedings, reliable drug testing can help establish patterns of substance use, monitor abstinence, and support safeguarding measures.

Legal professionals and social workers often rely on ‘wide-window’ (long-term) drug testing methods, such as hair and nail analysis, to assess a person’s historical drug use over several months. However, these methods cannot detect very recent consumption, which can be critical for assessing immediate risks to children.

This is where oral fluid (saliva) drug testing comes into its own.

A ‘narrow-window’ solution for real-time insight

Oral fluid (saliva) drug testing is classified as a ‘narrow-window’ (short-term) testing method, meaning it can be used to detect very recent drug use (up to 48 hours after drugs were first consumed).

During an oral fluid test, a sample of saliva is collected using an absorbent swab. The swab is then placed inside a screening device, providing results within minutes.

If drugs are detected, further analysis is carried out at our UKAS 17025-accredited laboratory to confirm the results.

The many benefits of oral fluid drug testing include:

  • Quick, easy-to-use and non-invasive
  • Immediate assessment—helping determine if a child is at immediate risk due to parental drug use
  • Tamper-proof—directly observed sample collection makes oral fluid samples very difficult to adulterate, unlike wearable drug tests that can be removed, contaminated or damaged
  • Cost-effective—no need for multiple appointments
  • Wide range of substances detected
  • Easy to administer with no special facilities required (unlike urine drug tests), making it ideal for home visits, unannounced checks, and emergency assessments

A comprehensive picture

While oral fluid drug testing is highly effective for detecting recent drug use, it does not provide insight into a person’s long-term substance use.

Where a holistic picture is needed, oral fluid testing therefore acts as the perfect complement to hair and/or nail drug tests.

Why is it important to combine narrow-window and wide-window drug tests?
  • Supports abstinence monitoring—hair and nail drug testing can confirm whether an individual has been abstinent over time, while oral fluid testing can help verify recent compliance
  • Ensures a balanced assessment—family cases benefit from immediate and historical insights, allowing for better-informed safeguarding decisions
  • Prevents misinterpretation—a negative oral fluid test does not mean a person is drug-free; it may simply mean they have not used drugs in the past 48 hours

Why choose AlphaBiolabs?

  • Rapid results from our UK laboratory
  • Widest range of drugs tested
  • User-friendly reports
  • UKAS 17025-accredited laboratory with Lab 51 extension for toxicology samples
  • Sample collections from any location within 24-48 hours of instruction
  • FREE legally-instructed sample collections at our nationwide walk-in centres
  • Price Promise: we will beat any like-for-like quote by a further 10%


Legal clients can get an AlphaBiolabs oral fluid test for half price (£49) until 30 June 2025. Simply quote OF49 when placing an order for a hair or nail drug test*

For more information, contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or complete our online quote form https://www.alphabiolabs.co.uk/legal-test-forms/.

*Oral fluid test must be performed at the same time as hair/nail sample collection.

Marie Law, Head of Toxicology at AlphaBiolabs
A highly-skilled and respected scientist with over 15 years’ experience in the field of forensics, Marie joined AlphaBiolabs in 2022 and oversees the company’s growing toxicology team.
As Head of Toxicology, Marie’s day-to-day responsibilities include maintaining the highest quality testing standards for toxicology and further enhancing AlphaBiolabs’ drug and alcohol testing services for the legal sector, members of the public, and the workplace sector.

MOVERS & SHAKERS

Charles Russell Speechlys—Matthew Griffin

Charles Russell Speechlys—Matthew Griffin

Firm strengthens international funds capability with senior hire

Gilson Gray—Jeremy Davy

Gilson Gray—Jeremy Davy

Partner appointed as head of residential conveyancing for England

DR Solicitors—Paul Edels

DR Solicitors—Paul Edels

Specialist firm enhances corporate healthcare practice with partner appointment

NEWS
The proposed £11bn redress scheme following the Supreme Court’s motor finance rulings is analysed in this week’s NLJ by Fred Philpott of Gough Square Chambers
In this week's issue, Stephen Gold, NLJ columnist and former district judge, surveys another eclectic fortnight in procedure. With humour and humanity, he reminds readers that beneath the procedural dust, the law still changes lives
Generative AI isn’t the villain of the courtroom—it’s the misunderstanding of it that’s dangerous, argues Dr Alan Ma of Birmingham City University and the Birmingham Law Society in this week's NLJ
James Naylor of Naylor Solicitors dissects the government’s plan to outlaw upward-only rent review (UORR) clauses in new commercial leases under Schedule 31 of the English Devolution and Community Empowerment Bill, in this week's NLJ. The reform, he explains, marks a seismic shift in landlord-tenant power dynamics: rents will no longer rise inexorably, and tenants gain statutory caps and procedural rights
Writing in NLJ this week, James Harrison and Jenna Coad of Penningtons Manches Cooper chart the Privy Council’s demolition of the long-standing ‘shareholder rule’ in Jardine Strategic v Oasis Investments
back-to-top-scroll